These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15953712)

  • 1. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
    Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Le Brun V; Wagner T
    Int J Pharm; 2005 Aug; 299(1-2):84-91. PubMed ID: 15970409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets.
    Streubel A; Siepmann J; Dashevsky A; Bodmeier R
    J Control Release; 2000 Jun; 67(1):101-10. PubMed ID: 10773333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
    Riis T; Bauer-Brandl A; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2007 Jan; 65(1):78-84. PubMed ID: 16919924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multiple unit pellet formulation for a weakly basic drug.
    Guthmann C; Lipp R; Wagner T; Kranz H
    Drug Dev Ind Pharm; 2007 Mar; 33(3):341-9. PubMed ID: 17454067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.
    Siepe S; Herrmann W; Borchert HH; Lueckel B; Kramer A; Ries A; Gurny R
    J Control Release; 2006 May; 112(1):72-8. PubMed ID: 16476499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel osmotically driven drug delivery system for weakly basic drugs.
    Guthmann C; Lipp R; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):667-74. PubMed ID: 18226884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a robust once-a-day glipizide matrix system.
    Jamzad S; Fassihi R
    J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The control of drug release of heavy-soluble, weak basic drugs in matrix tablets using the example of medazepam].
    Zessin G; Fahr F; Mank R
    Pharmazie; 1986 Jan; 41(1):39-42. PubMed ID: 2870512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.